Leveraging Digital Health Solutions to Collect Patient-Reported Outcomes in Rectal Cancer

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT07811128
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Quality of Life Surveys — OTHER
    Patient-reported outcome measures: Assessment of Burden in Colorectal Cancer (ABCRC) \& Decisional Regret Scale (DRS)

Study Details

Rectal cancer care is increasingly complex and may include systemic therapy, radiation therapy, surgery, or nonoperative watch-and-wait surveillance. These treatments can have both short- and long-term effects on bowel, urinary, sexual, and stoma-related function. Prior studies have often assessed quality of life and treatment decision experiences at a single time point or after one type of treatment, resulting in limited information about how patients' experiences change throughout their course of care. This study will evaluate health-related quality of life and experiences with treatment decisions among patients with non-metastatic rectal cancer using validated patient-reported outcome measures over the course of treatment.

Key Dates

First listed
Sep 9, 2026
Start date
Oct 31, 2026
Status verified
Sep 2026
Primary completion
Nov 30, 2027
Completion
Nov 30, 2027

Study Design

Enrollment
150 participants (estimated)

Arms

  • Arm: Participants with rectal cancer
    Participants with non-metastatic rectal cancer and who are receiving treatment at UCSF.

Primary Outcome Measure

Proportion of scheduled MyChart survey events completed [ Time Frame: Up top 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, San FranciscoSan FranciscoCalifornia94143
Laleh Foroutani, MD
[email protected]
415-299-9424
Mark Zhao, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Francisco, CA

Nationwide
Colorectal cancer trialsOncology trialsGI oncology trials
By condition
Colorectal cancer
By specialty
OncologyGI oncology
By research site
University of California, San Francisco· San Francisco, CA

Related Studies